Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease - Test2 - elhamkhani - TriplyDB

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

http://www.wikidata.org/entity/Q28238269

about

Interactions of metals and Apolipoprotein E in Alzheimer's disease Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2 Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro Human APOE genotype affects intraneuronal Aβ1-42 accumulation in a lentiviral gene transfer model The apolipoprotein E gene, attention, and brain function Apolipoprotein E and Alzheimer disease Impact of apolipoprotein E on Alzheimer's disease Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play Genetic aspects of Alzheimer disease Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers The genetic landscape of Alzheimer disease: clinical implications and perspectives Role of apolipoprotein E in neurodegenerative diseases Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases The genetics of Alzheimer disease Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments The liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein E Rarity of the Alzheimer disease-protective APP A673T variant in the United States Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells Cognitive change and the APOE epsilon 4 allele The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease Buying time: a rationale for examining the use of circadian rhythm and sleep interventions to delay progression of mild cognitive impairment to Alzheimer's disease Additional mechanisms conferring genetic susceptibility to Alzheimer's disease Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift How Research on Human Progeroid and Antigeroid Syndromes Can Contribute to the Longevity Dividend Initiative Some evolutionary perspectives on Alzheimer's disease pathogenesis and pathology In vivo human apolipoprotein E isoform fractional turnover rates in the CNS Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset Haplotype Analysis and Linkage Disequilibrium at Five Loci in Eragrostis tef Isoform-specific effects of apoE on neurite outgrowth in olfactory epithelium culture Morphological, Biochemical, and Genetic Support for an Apolipoprotein E Effect on Microtubular Metabolisma

P2860

Q21131068-97670A7B-EBCF-4A01-B742-6F218464F389 Q21562116-C908D736-763C-4E45-9F06-049CE3D6AEA6 Q22248091-97C084F9-357C-4F65-8B43-9FE301B3208C Q24291128-7FF97C50-0C46-4FFA-B5D8-B78B5780C5ED Q24308731-42DBE7C9-9670-4B77-9A49-49DB94D7D29B Q24312075-EA92D6B3-D97E-4AE5-ABFD-2A2D26B01C25 Q24314295-76D210B9-1C72-4439-B80D-124C912229EE Q24321663-47CD8E90-9FF0-4BEA-BC67-8FFF84E3A058 Q24338827-D1F19544-ED62-46BD-AFF0-795E7F92DE73 Q24539024-23C6478D-7412-4AAF-B2BD-2E50A7347606 Q24563061-1D5946F1-279F-411C-9E70-960A1572A869 Q24567759-1D880125-8927-468E-B5E9-621A61D8AB45 Q24594531-AE4951AD-666B-4FA4-9548-7F2533815EB6 Q24604373-CE0688CA-B8B1-4543-8BBF-FD8858B75DE0 Q24610759-072A0790-D956-4A7C-83FB-3BE4A07DBD5B Q24616113-2AB913DC-A8F5-4BCA-94F2-53B175CA115A Q24629875-54825D23-878C-45E9-BDBC-AF16968C7396 Q24654145-E52C575C-3D11-4C01-9F4B-5F6F4CD5543B Q26796582-D88A8CFC-0896-4E16-AE6A-E41EFE7FF1AD Q26799413-25B11F31-46EF-4580-B72B-89A943B6F91C Q26858870-392BB7BF-4A1F-4DC9-8014-E6E5FE01F072 Q27009984-74D4C158-D115-4E7F-9E7C-28B2B01A634C Q27026166-3C69F6B0-8370-4B72-9CF0-7830DFD844E7 Q27026362-D44D2EE6-223A-4F9E-B0A5-8A69943ACAB2 Q27321301-FEBDD6F5-E561-4B43-8CE7-F5E5B09C9D77 Q27346292-996BD5EC-8355-4D1B-AA1F-341142492AC2 Q28189379-204520A0-30AC-49F0-A5FA-2D01B210DD28 Q28219219-7FCBA267-33B2-4A69-AA0D-4751102371AB Q28370052-37659318-5AC7-47E3-9B3E-5C170FBB527A Q28383805-9C82F63A-EB21-4350-AD5E-EF1C1F17811D Q28391511-C916BD80-B009-4A50-9195-7461FC46573E Q28533723-9925AE3A-F44F-4868-9A37-A590F17464A7 Q28582464-52840016-73D3-4095-B635-EB00EEE3CFF6 Q28601451-E8AB55CD-6BD8-4D35-AE90-A0D515502486 Q28705398-67E9EAFB-2EDB-4595-B89B-A7D310C352A6 Q28728902-4B3DFD6A-F19E-4BFD-88D6-E66FE85E8343 Q28730795-A689001F-EECA-4B9E-85F0-E5448141194A Q28731611-AC7ABA6A-1877-4ED3-84C5-E2E22A3CE0B0 Q28771485-101056C1-61B3-4245-84C5-A23FAC7A3572 Q29041808-C5654F1A-75D5-4107-B7D5-D3AE2D1B3A7F

P2860

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

http://www.wikidata.org/entity/Q28238269

description

1994 nî lūn-bûn

@nan

1994 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

@ast

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

@en

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

@nl

type

label

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

@ast

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

@en

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

@nl

prefLabel

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

@ast

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

@en

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

@nl

P1433

Q28238269-06C1132B-5246-41EC-AF09-1FE1931ACDCA

P1476

Q28238269-EF66F4A3-EE61-473C-AF4A-5B8DA47D0B5D

P2093

Q28238269-1F95A366-5460-4D25-84C9-68B1804B936A

Q28238269-212A49C5-983D-4EDF-9339-54CB0271F1B7

Q28238269-3B4564C0-96AD-44DA-BB55-1F3E502A55A6

Q28238269-7D04E330-0476-4D7D-A230-A961C90D5C3A

Q28238269-82F6C5EA-7B7F-4389-B103-89EFB4C174E3

Q28238269-99D419C0-3202-4CFB-96AC-800F17A7E867

Q28238269-A4AB3CE6-597E-41CC-BD3C-61A022CC7E58

Q28238269-C04E8F52-5846-4441-ABA2-C07A861C36DE

Q28238269-E0C0EB50-12AD-425E-866D-EE80F0C8AB07

Q28238269-F7BE35CC-4375-4879-B849-02A6AC729F9B

P2888

Q28238269-0BB1B474-7B26-4EF5-8F0E-D324C3079386

P304

Q28238269-745C86E8-04DF-457B-942C-57EC8D3A54F5

P31

Q28238269-A1136B95-2531-429F-A94B-F5BEDC6D9BA0

P3181

Q28238269-B722D8F2-C219-4158-BDA3-EA8B32F63B55

P356

Q28238269-F86E43E7-8608-4C3C-A0D6-075671C8543A

P407

Q28238269-5C8EF307-8D68-46E3-9138-BAB76CECC6FB

P433

Q28238269-1436332A-517A-4A59-857D-27907075253B

P478

Q28238269-E365C2E8-1F62-4970-A149-1D1B8659E1D5

P577

Q28238269-03918620-79C4-4BB9-88C6-A81BCB83B03B

P5875

Q28238269-76F6B98A-EAE2-4260-A18F-70AFC1EE0044

P6179

Q28238269-064B79A3-FA98-4AB9-BCD8-2E80C9173F47

P698

Q28238269-182D7EF0-F657-41CD-A36E-BD869149E87A

P921

Q28238269-4C2A1308-BA2A-422B-BAC8-17E4AE0B9B97

P3181

P356

P1433

Nature Genetics

P1476

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

@en

P2093

A M Saunders

http://www.w3.org/2001/XMLSchema#string

D E Schmechel

http://www.w3.org/2001/XMLSchema#string

E H Corder

http://www.w3.org/2001/XMLSchema#string

J B Rimmler

http://www.w3.org/2001/XMLSchema#string

K E Schmader

http://www.w3.org/2001/XMLSchema#string

N J Risch

http://www.w3.org/2001/XMLSchema#string

P A Locke

http://www.w3.org/2001/XMLSchema#string

P C Gaskell

http://www.w3.org/2001/XMLSchema#string

P M Conneally

http://www.w3.org/2001/XMLSchema#string

W J Strittmatter

http://www.w3.org/2001/XMLSchema#string

P2888

P304

180-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2388305

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NG0694-180

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

1994-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15277873

http://www.w3.org/2001/XMLSchema#string

P6179

1022434631

http://www.w3.org/2001/XMLSchema#string

P698

7920638

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease